Ovid Therapeutics (OVID) Q3 2025 Earnings

13AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.21
-0.16
-0.11
-0.06

Details

Expected EPS
-0.157871
Actual EPS
-0.06
Surprise EPS
0.1
Surprise Percent
+61.99%

Description

Ovid Therapeutics (OVID) has reported earnings of -0.06 per share for Q3 2025.

0 Comments

Share your thoughts